DCSZ11
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DCSZ11, covering 2025-06-26 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]